These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37029362)

  • 1. Healthcare expenditure and technology use in pediatric diabetes care.
    de Vries SAG; Bak JCG; Verheugt CL; Stangenberger VA; Mul D; Wouters MWJM; Nieuwdorp M; Sas TCJ
    BMC Endocr Disord; 2023 Apr; 23(1):72. PubMed ID: 37029362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing costs of type 1 diabetes care among US children and adolescents.
    Crossen S; Xing G; Hoch JS
    Pediatr Diabetes; 2020 Jun; 21(4):644-648. PubMed ID: 32061049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does size matter? Hospital volume and resource use in paediatric diabetes care.
    de Vries SAG; Bak JCG; Mul D; Wouters MWJM; Nieuwdorp M; Verheugt CL; Sas TCJ
    Diabet Med; 2024 May; 41(5):e15260. PubMed ID: 38018287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4).
    Spaans EAJM; van Dijk PR; Groenier KH; Brand PLP; Kleefstra N; Bilo HJG
    BMC Endocr Disord; 2018 Aug; 18(1):57. PubMed ID: 30119628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hospital care among Dutch diabetes patients.
    de Vries SAG; Bak JCG; Stangenberger VA; Wouters MWJM; Nieuwdorp M; Sas TCJ; Verheugt CL
    Diabetes Obes Metab; 2023 Aug; 25(8):2268-2278. PubMed ID: 37157933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(2):1-160. PubMed ID: 29541282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of direct costs of type 1 diabetes mellitus in Andalusian patients aged 2-16 years.
    Álvarez Casaño M; Alonso Montejo MDM; Leiva Gea I; Jiménez Hinojosa JM; Santos Mata MÁ; Macías F; Romero Pérez MDM; de Toro M; Martínez G; Munguira P; Vivas G; López Siguero JP
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):480-486. PubMed ID: 31122889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes.
    Norman GJ; Paudel ML; Parkin CG; Bancroft T; Lynch PM
    Diabetes Technol Ther; 2022 Jul; 24(7):520-524. PubMed ID: 35230158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of periodontal treatment on diabetes-related healthcare costs. A retrospective study].
    Smits KPJ; Kalmus O; Plachokova AS; van der Galien O; Listl S
    Ned Tijdschr Tandheelkd; 2021 Jun; 128(6):317-322. PubMed ID: 34096931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct health care costs of diabetic patients in Spain.
    Oliva J; Lobo F; Molina B; Monereo S
    Diabetes Care; 2004 Nov; 27(11):2616-21. PubMed ID: 15504995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of diabetes mellitus type 2 and self measurement of blood glucose in Germany].
    Weber C; Neeser K; Wenzel H; Schneider B
    Versicherungsmedizin; 2006 Sep; 58(3):133-7. PubMed ID: 17002177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.